Treace Medical Concepts (TMCI) Q2 FY26 earnings call

Treace Medical Concepts reported Q2 FY26 results showing sequential revenue growth improvement and enhanced profitability, driven by strong adoption of new bunion systems and accelerating case volumes. The company is expanding its portfolio beyond bunion correction into broader foot and ankle procedures, with several new product launches and commercialization efforts underway in the second half of the year. Management raised full-year revenue and adjusted EBITDA guidance, anticipating a return to positive revenue growth in Q4.